Importantly, the percentage of LRHL patients carrying the NCF1 rs77759698 variant was 75% and that of MCHL patients carrying the ADAM12 rs144561426 and TTLL5 rs375900619 were 100% and 66.67%, respectively. This evidence concerns the gene ADAM12 and Hodgkin's lymphoma, mixed cellularity.